162 related articles for article (PubMed ID: 28548282)
1. Estimating the effect of immortal-time bias in urological research: a case example of testosterone-replacement therapy.
Wallis CJD; Saskin R; Narod SA; Law C; Kulkarni GS; Seth A; Nam RK
BJU Int; 2017 Oct; 120(4):584-590. PubMed ID: 28548282
[TBL] [Abstract][Full Text] [Related]
2. Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study.
Wallis CJ; Lo K; Lee Y; Krakowsky Y; Garbens A; Satkunasivam R; Herschorn S; Kodama RT; Cheung P; Narod SA; Nam RK
Lancet Diabetes Endocrinol; 2016 Jun; 4(6):498-506. PubMed ID: 27165609
[TBL] [Abstract][Full Text] [Related]
3. Testosterone replacement therapy and the risk of stroke in men: A systematic review.
Loo SY; Chen BY; Yu OHY; Azoulay L; Renoux C
Maturitas; 2017 Dec; 106():31-37. PubMed ID: 29150164
[TBL] [Abstract][Full Text] [Related]
4. Immortal time bias in drug safety cohort studies: spontaneous abortion following nonsteroidal antiinflammatory drug exposure.
Daniel S; Koren G; Lunenfeld E; Levy A
Am J Obstet Gynecol; 2015 Mar; 212(3):307.e1-6. PubMed ID: 25265406
[TBL] [Abstract][Full Text] [Related]
5. Testosterone replacement therapy in men with prostate cancer: a time-varying analysis.
Kaplan AL; Lenis AT; Shah A; Rajfer J; Hu JC
J Sex Med; 2015 Feb; 12(2):374-80. PubMed ID: 25496237
[TBL] [Abstract][Full Text] [Related]
6. Testosterone therapy and risk of myocardial infarction: a pharmacoepidemiologic study.
Etminan M; Skeldon SC; Goldenberg SL; Carleton B; Brophy JM
Pharmacotherapy; 2015 Jan; 35(1):72-8. PubMed ID: 25582846
[TBL] [Abstract][Full Text] [Related]
7. Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time bias.
Kiri VA; Pride NB; Soriano JB; Vestbo J
Am J Respir Crit Care Med; 2005 Aug; 172(4):460-4. PubMed ID: 15901610
[TBL] [Abstract][Full Text] [Related]
8. Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes.
Muraleedharan V; Marsh H; Kapoor D; Channer KS; Jones TH
Eur J Endocrinol; 2013 Dec; 169(6):725-33. PubMed ID: 23999642
[TBL] [Abstract][Full Text] [Related]
9. The appropriateness and persistence of testosterone replacement therapy in Ontario.
Martins D; Yao Z; Tadrous M; Shah BR; Juurlink DN; Mamdani MM; Gomes T;
Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):119-126. PubMed ID: 27528454
[TBL] [Abstract][Full Text] [Related]
10. The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology Example.
Duchesneau ED; Jackson BE; Webster-Clark M; Lund JL; Reeder-Hayes KE; Nápoles AM; Strassle PD
Cancer Epidemiol Biomarkers Prev; 2022 Nov; 31(11):2079-2086. PubMed ID: 35984990
[TBL] [Abstract][Full Text] [Related]
11. Factors that may be influencing the rise in prescription testosterone replacement therapy in adult men: a qualitative study.
Mascarenhas A; Khan S; Sayal R; Knowles S; Gomes T; Moore JE
Aging Male; 2016 Jun; 19(2):90-5. PubMed ID: 26927629
[TBL] [Abstract][Full Text] [Related]
12. Impact of immortal person-time and time scale in comparative effectiveness research for medical devices: a case for implantable cardioverter-defibrillators.
Mi X; Hammill BG; Curtis LH; Greiner MA; Setoguchi S
J Clin Epidemiol; 2013 Aug; 66(8 Suppl):S138-44. PubMed ID: 23849148
[TBL] [Abstract][Full Text] [Related]
13. Serum testosterone, testosterone replacement therapy and all-cause mortality in men with type 2 diabetes: retrospective consideration of the impact of PDE5 inhibitors and statins.
Hackett G; Heald AH; Sinclair A; Jones PW; Strange RC; Ramachandran S
Int J Clin Pract; 2016 Mar; 70(3):244-53. PubMed ID: 26916621
[TBL] [Abstract][Full Text] [Related]
14. Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men.
Sharma R; Oni OA; Gupta K; Chen G; Sharma M; Dawn B; Sharma R; Parashara D; Savin VJ; Ambrose JA; Barua RS
Eur Heart J; 2015 Oct; 36(40):2706-15. PubMed ID: 26248567
[TBL] [Abstract][Full Text] [Related]
15. Immortal time bias in observational studies of drug effects in pregnancy.
Matok I; Azoulay L; Yin H; Suissa S
Birth Defects Res A Clin Mol Teratol; 2014 Sep; 100(9):658-62. PubMed ID: 24985740
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D supplementation for prevention of mortality in adults.
Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C
Cochrane Database Syst Rev; 2014 Jan; (1):CD007470. PubMed ID: 24414552
[TBL] [Abstract][Full Text] [Related]
17. Metformin and pancreatic cancer survival: Real effect or immortal time bias?
Wei M; Liu Y; Bi Y; Zhang ZJ
Int J Cancer; 2019 Oct; 145(7):1822-1828. PubMed ID: 30848544
[TBL] [Abstract][Full Text] [Related]
18. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
19. Association Between Testosterone Replacement Therapy and the Incidence of DVT and Pulmonary Embolism: A Retrospective Cohort Study of the Veterans Administration Database.
Sharma R; Oni OA; Chen G; Sharma M; Dawn B; Sharma R; Parashara D; Savin VJ; Barua RS; Gupta K
Chest; 2016 Sep; 150(3):563-71. PubMed ID: 27179907
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
